Dalton Investments, a major shareholder of Aska Pharmaceuticals and Bunka Shutter, has sent a letter to both companies criticizing their adoption of a “Response Policy on Large-Scale Purchase of Shares”. The letter outlines four key points of Dalton’s position. Read the letter here.
